Literature DB >> 26077362

Role of leptin and leptin receptors in hematological malignancies.

Shahab Uddin1, Ramzi M Mohammad1.   

Abstract

Leptin is an adipose-derived cytokine that has an important role in bodyweight homeostasis and energy balance. There are a number of studies which have suggested that leptin and its receptors dysregulation play a critical role in the development of malignancies including hematological malignancies, mainly via activation of the JAK/STAT pathway which regulates downstream signaling pathways such as PI3K/AKT signaling and ERK1/2. In this review, current understandings of leptin/leptin receptors mediated pathogenesis in various lymphoid malignancies are described. Blocking of the leptin receptor might be a unique therapeutic approach for many hematological malignancies.

Entities:  

Keywords:  Leptin; Ob-R; PI3-kInase/AKT pathway; leukemia; lymphoma

Mesh:

Substances:

Year:  2015        PMID: 26077362     DOI: 10.3109/10428194.2015.1063145

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

Review 1.  Does persistent HIV replication explain continued lymphoma incidence in the era of effective antiretroviral therapy?

Authors:  Jennifer Totonchy; Ethel Cesarman
Journal:  Curr Opin Virol       Date:  2016-09-23       Impact factor: 7.090

Review 2.  Leptin: an unappreciated key player in SLE.

Authors:  Qihang Yuan; Haifeng Chen; Xia Li; Jing Wei
Journal:  Clin Rheumatol       Date:  2019-11-09       Impact factor: 2.980

3.  Leptin and insulin up-regulate miR-4443 to suppress NCOA1 and TRAF4, and decrease the invasiveness of human colon cancer cells.

Authors:  Ari Meerson; Hila Yehuda
Journal:  BMC Cancer       Date:  2016-11-14       Impact factor: 4.430

Review 4.  The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance.

Authors:  Minh Ngoc Duong; Aline Geneste; Frederique Fallone; Xia Li; Charles Dumontet; Catherine Muller
Journal:  Oncotarget       Date:  2017-05-20

5.  CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting.

Authors:  Niklas Landberg; Sofia von Palffy; Maria Askmyr; Henrik Lilljebjörn; Carl Sandén; Marianne Rissler; Satu Mustjoki; Henrik Hjorth-Hansen; Johan Richter; Helena Ågerstam; Marcus Järås; Thoas Fioretos
Journal:  Haematologica       Date:  2017-12-28       Impact factor: 9.941

Review 6.  Roles of omental and bone marrow adipocytes in tumor biology.

Authors:  Yoon Jin Cha; Ja Seung Koo
Journal:  Adipocyte       Date:  2019-12       Impact factor: 4.534

Review 7.  Abnormal bone marrow microenvironment: the "harbor" of acute lymphoblastic leukemia cells.

Authors:  Zehui Chen; Yaxin Zheng; Yaling Yang; Junnan Kang; M James You; Chen Tian
Journal:  Blood Sci       Date:  2021-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.